Corrigendum: Mesenchymal stromal cell derived extracellular vesicles as a therapeutic tool: immune regulation, MSC priming, and applications to SLE

Christophe Wong; Ivana Stoilova; Florence Gazeau; Jean-Philippe Herbeuval; Thibaut Fourniols

doi:10.3389/fimmu.2024.1386412

Corrigendum: Mesenchymal stromal cell derived extracellular vesicles as a therapeutic tool: immune regulation, MSC priming, and applications to SLE

Front Immunol. 2024 Apr 8:15:1386412. doi: 10.3389/fimmu.2024.1386412. eCollection 2024.

Authors

Christophe Wong^{1

2

3}, Ivana Stoilova^{2

3}, Florence Gazeau⁴, Jean-Philippe Herbeuval^#^{2

3}, Thibaut Fourniols^#¹

Affiliations

¹ EVerZom, Paris, France.
² Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 8601, Université Paris Cité, Paris, France.
³ Chemistry and Biology, Modeling and Immunology for Therapy (CBMIT), Université Paris Cité, Paris, France.
⁴ Matière et Systèmes Complexes (MSC) UMR CNRS 7057, Université Paris Cité, Paris, France.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2024.1355845.].

Keywords: extracellular vesicles; immune regulation; mesenchymal stromal cell; priming; secretome; systemic lupus erythematosus.

Publication types

Published Erratum

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. CW is a student from the FIRE PhD program funded by the Bettencourt Schueller foundation and the EURIP graduate program (ANR-17-EURE-0012). IS is a student from the MTCI PhD program, and this work was supported by the Fondation pour la Recherche Médicale, grant number ECO202306017404.